Business Wire

CO-CSG

15.3.2023 14:31:41 CET | Business Wire | Press release

Share
CSG Awarded Patent for Zero-Code Ecosystem Design

B2C-style experiences with instant gratification and offer personalization are the new standards for all industries and communication service providers (CSPs) are not immune to this pressure. To lead CSPs into this new era of customer experience, CSG® (NASDAQ: CSGS) announced that it has been awarded a patent in the US and Australia for CSG Encompass. The platform enables telcos to expand their portfolios with products and services from partners and tap into the promise of a lucrative B2B2X market. The patent anchors CSG's position as an industry leader in B2B2X and protects its unique design for powering a frictionless user experience.

“CSPs need a catalogue-driven solution that allows flexible, scalable and repeatable collaboration across partners to capitalize on the evolving opportunities in B2B2X,” said Greg Tilton, VP Catalogue, Quote & Order, CSG. “CSG Encompass does exactly that. It allows operators to launch new services faster and seamlessly bolster their business with more personalized customer experiences for both the enterprise and consumers. To be granted this patent is a significant milestone for CSG, and we are proud to lead the industry with a solution proven to make it easier for CSPs to move beyond connectivity."

CSG Encompass allows CSPs to easily create, bundle, and launch new products and services. With CSG's patented solution, offers can be built from CSP and partner components and then quoted, ordered, and managed with zero code required. Built on TM Forum ODA and Open API standards, this technology means partnerships between CSPs and their partners can be created with zero IT integration cost. Doing so makes it easier, faster and cheaper for CSPs to offer innovative new products and services.

“Enterprises and their partners alike want to interact and transact digitally without having to make significant investments into the creation of components from multiple suppliers themselves,” said John Abraham, principal analyst, Appledore Research. “B2B2X ecosystems, which bring together digital services from several partners, are the foundation for delivering these seamless experiences. To be successful, they require an open, integrated solution that can manage the complex commerce cycles needed for CSPs to engage with a more diverse range of partners. This patent reinforces CSG’s emphasis on helping telco operators resolve the complexities of B2B2X marketplaces and capitalize on new monetization opportunities.”

Recognized as a TM Forum Catalyst finalist with the first phase of its Channel & Markets project, CSG has proven Encompass as the most effective end-to-end platform to solve the B2B2X zero-touch challenge. The second phase now tests some proposed enhancements to API standards and will be showcased during DTW Asia 2023. From the outset, CSG has been a significant contributor to the MEF SONATA SDK and TM Forum Open APIs. This patent is a testament to CSG's commitment to advancing the industry and enabling CSPs to use these standards effectively and successfully to thrive in the digital economy and beyond.

About CSG

CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our more than 5k-strong experienced global CSG services team.

Want to learn more about how to be a change-maker and industry shaper like our 1,000-plus clients? Visit csgi.com to learn more.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230315005005/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release

Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye